These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4745832

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Injection method for delivery of long-acting narcotic antagonists.
    Leafe TD, Sarner SF, Woodland JH, Yolles S, Blake DA, Meyer FJ.
    Adv Biochem Psychopharmacol; 1973; 8(0):569-75. PubMed ID: 4794963
    [No Abstract] [Full Text] [Related]

  • 3. Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites.
    Yolles S, Leafe TD, Woodland JH, Meyer FJ.
    J Pharm Sci; 1975 Feb; 64(2):348-9. PubMed ID: 1127596
    [Abstract] [Full Text] [Related]

  • 4. In vivo and in vitro evaluation of a microencapsulated narcotic antagonist.
    Mason N, Thies C, Cicero TJ.
    J Pharm Sci; 1976 Jun; 65(6):847-50. PubMed ID: 932970
    [Abstract] [Full Text] [Related]

  • 5. Narcotic antagonists: the search accelerates.
    Maugh TH.
    Science; 1972 Jul 21; 177(4045):249-50. PubMed ID: 5041023
    [No Abstract] [Full Text] [Related]

  • 6. [Application of cyclazocine in modified neuroleptanesthesia].
    Niiya S, Hirano K, Hara K, Miyoshi Y, Yukinari T, Itohda Y, Haseba S, Gotoh Y, Nakamura H.
    Masui; 1983 Mar 21; 32(3):310-5. PubMed ID: 6864995
    [No Abstract] [Full Text] [Related]

  • 7. Biocompatible implants for the sustained zero-order release of narcotic antagonists.
    Abrahams RA, Ronel SH.
    J Biomed Mater Res; 1975 May 21; 9(3):355-66. PubMed ID: 1176491
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The metabolic fate of H3-cyclazocine in dogs.
    Mulé SJ, Clements TH, Gorodetzky CW.
    J Pharmacol Exp Ther; 1968 Apr 21; 160(2):387-96. PubMed ID: 5239862
    [No Abstract] [Full Text] [Related]

  • 13. Studies of EN-1639A (naltrexone): a new narcotic antagonist.
    Resnick RB, Volavka J, Freedman AM, Thomas M.
    Am J Psychiatry; 1974 Jun 21; 131(6):646-50. PubMed ID: 4827793
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical studies of cyclazocine in the treatment of narcotic addiction.
    Freedman AM, Fink M, Sharoff R, Zaks A.
    Am J Psychiatry; 1968 May 21; 124(11):1499-504. PubMed ID: 4869436
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists.
    Pitt CG, Marks TA, Schindler A.
    NIDA Res Monogr; 1981 May 21; 28():232-53. PubMed ID: 6791007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.